Trial Profile
Single-Blind, Randomized Study of the Comparative Drug Likeability and Pharmacokinetics of Vyvanse and ADDERALL XR When Administered as a Solution.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 11 Jun 2021
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary) ; Mixed amfetamine salts (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Sponsors Shire
- 07 Apr 2009 Planned end date changed from 1 Oct 2009 to 1 Mar 2009 as reported by ClinicalTrials.gov.
- 07 Apr 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 07 Apr 2009 Actual patient number (3) added as reported by ClinicalTrials.gov.